Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and Exercise for Cancer-Related Fatigue
NCT03583255Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2018
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in cancer-related fatigue (CRF), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2018; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT03583255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03583255.